We are live on ! Find out more
NVNO

enVVeno Medical

9 hedge funds and large institutions have $261K invested in enVVeno Medical in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding

Funds holding: 39 (+6)

9% more capital invested

Capital invested by funds: $240K → $261K (+$21K)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
9
Holders Change
+6
Holders Change %
+200%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

NVNO Hedge Fund Activity: Q3 2019 in Review

9 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q3 2019, worth a combined $261K — up 8.8% from $240K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NVNO positions and 0 closed out — a net gain of 6 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was MYDA Advisors, opening a new position worth an estimated $60.9K. The largest seller was Vanguard Group, cutting an estimated $86.9K.

  • 9 institutional investors held enVVeno Medical (NVNO) as of Q3 2019, up from 3 in Q2 2019.
  • Funds reported $261K of enVVeno Medical stock for Q3 2019, up 8.8% quarter-over-quarter.
  • 6 funds opened new enVVeno Medical positions in Q3 2019 and 0 closed out, a net change of +6 holders.
  • The largest enVVeno Medical buyer in Q3 2019 was MYDA Advisors, an estimated $60.9K added.
  • The largest enVVeno Medical seller in Q3 2019 was Vanguard Group, an estimated $86.9K sold.

Based on aggregated 13F filings for Q3 2019.